TRT Myths: Does Testosterone Therapy Cause Prostate Cancer or Heart Problems?
For a lot of men, the decision about testosterone replacement therapy (TRT) comes down to two nagging fears they've heard somewhere along the way: doesn't testosterone cause prostate cancer? and won't it hurt my heart?
These are exactly the right questions to ask — and they deserve honest, up-to-date answers rather than either hype or fear. The good news is that the science on both has advanced significantly in recent years, and much of what people "know" about TRT is based on outdated ideas that better research has since overturned. Let's walk through both myths and what the current evidence actually shows.
Myth #1: "Testosterone causes prostate cancer"
This is the most persistent TRT myth, and it has a long history. It traces back to research from the 1940s showing that lowering testosterone slowed advanced prostate cancer. From there, the logic seemed simple: if less testosterone slows prostate cancer, more testosterone must fuel it. For decades, that assumption stuck.
But modern research has not borne it out. A growing body of evidence — including recent studies following men on testosterone therapy — has found that men with genuinely low testosterone who are appropriately treated do not show a higher risk of developing prostate cancer than men who aren't treated.
The explanation comes from what researchers call the saturation model. The idea is that the prostate's androgen receptors — the docks where testosterone attaches — become fully "saturated" at relatively low testosterone levels. Once those docks are full, adding more testosterone doesn't further stimulate the prostate, because there's nowhere left for the extra to attach. It's a bit like watering a plant: up to a point water helps, but past saturation, pouring on more doesn't make it grow faster. This helps explain why raising a low testosterone level up into a healthy range doesn't appear to "feed" prostate cancer the way the old model predicted.
The honest, important caveat: this does not mean testosterone is a free-for-all. An active, known prostate cancer remains a clear reason not to start TRT, and responsible treatment always includes checking a PSA (prostate-specific antigen) and doing appropriate prostate screening before therapy — and then monitoring it during treatment. The reassurance here isn't "prostate health doesn't matter." It's that properly screened and monitored testosterone therapy, in men who actually need it, is not the prostate cancer trigger it was once feared to be.
Myth #2: "Testosterone therapy is bad for your heart"
This fear is more recent. Around a decade ago, a couple of studies suggested TRT might raise the risk of heart attacks and strokes. The headlines spread quickly. What got far less attention was that those studies had significant flaws, and the concern they raised was never well established.
To settle the question, researchers ran a large, rigorous clinical trial — the kind of study that carries real weight. Called TRAVERSE, it followed more than 5,000 middle-aged and older men who had low testosterone plus existing heart disease or a high risk for it — in other words, men you'd expect to be most vulnerable if TRT really were hard on the heart.
The result was reassuring: testosterone therapy did not increase the rate of major cardiac events like heart attack, stroke, or cardiovascular death compared to placebo. For men with genuine testosterone deficiency, this was strong evidence against the "TRT wrecks your heart" narrative.
The honest caveat again: the same trial did find a few conditions that occurred somewhat more often in the testosterone group, including an irregular heart rhythm called atrial fibrillation and a type of blood clot in the lungs. That's not a reason to panic, but it is a reason to be treated by someone who screens you properly and monitors you over time — not to buy testosterone off the internet or from a "low-T" mill that hands it out without oversight. It's also worth being clear that these findings apply to men with genuinely low testosterone taking appropriate doses — not to athletes or bodybuilders using very high amounts, where the risk picture is completely different.
What actually makes TRT safe
If there's one theme running through both myths, it's this: the safety of testosterone therapy has far less to do with testosterone being "good" or "bad," and far more to do with how it's done. Responsible, well-managed TRT looks very different from the horror stories.
Good care starts with an accurate diagnosis — confirming with proper bloodwork that your testosterone is genuinely low and that your symptoms match, rather than treating a number in isolation. It includes baseline safety labs before you ever start: a PSA and prostate check, a blood count to measure your hematocrit (since testosterone can thicken the blood, which needs watching), and a review of your heart health and personal risk factors. And it means ongoing monitoring — rechecking these markers at regular intervals and adjusting your plan as needed.
It also means honoring the real contraindications. There are situations where TRT genuinely isn't appropriate — an active prostate or breast cancer, a blood count that's already too high, certain untreated heart conditions — and a careful provider screens for all of them before writing a prescription. Done this way, the goal isn't to chase the highest possible number; it's to restore your levels to a healthy, optimal range and keep you safe the entire way.
The bottom line
For a man with genuinely low testosterone and symptoms to match, today's best evidence is reassuring: appropriately managed TRT does not appear to cause prostate cancer, and it has not been shown to increase major cardiac events. The fears that keep so many men from getting help are largely rooted in older, weaker science that stronger studies have since corrected.
That said, "appropriately managed" is doing real work in that sentence. TRT is a medical therapy that deserves proper diagnosis, honest screening, and ongoing monitoring — which is exactly the kind of care that separates safe, effective treatment from the cautionary tales.
At Finger Lakes FNP, that's how we practice men's hormone optimization: thorough testing up front, careful monitoring throughout, and an honest conversation about whether TRT is right for you.
Call to book a consult today at (607) 638-2492, and let's talk through your questions — including these — with real answers.
-Melissa Vorhis, DNP, FNP-C
This article is for educational purposes only and is not a substitute for individualized medical advice. Testosterone therapy requires proper evaluation, screening for contraindications, informed consent, and ongoing monitoring with a qualified provider. Please consult us or your healthcare provider before starting or changing any treatment.
Comments